Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients
Sponsor: University of Florida
Summary
This pilot study will investigate the potential efficacy of VM100, a nutritional supplement specifically formulated for patients with DMD, on quality of life and physical symptoms. Twenty patients (aged 8 an over) will be enrolled to undergo a 10-week placebo-controlled intervention with VM100. Outcomes will include validated questionnaires and qualitative interview to assess impact on mental, cognitive and mood related measures, as well as endurance and fatigue).
Key Details
Gender
MALE
Age Range
6 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-07-27
Completion Date
2028-12
Last Updated
2026-08-17
Healthy Volunteers
No
Conditions
Interventions
VM100 Nutritional Supplement
VM100 is an investigational dietary supplement formulated specifically for individuals with Duchenne muscular dystrophy. It contains ten naturally derived ingredients formulated using a proprietary technology to enhance bioavailability. The supplement is intended to support mitochondrial function, reduce inflammation and oxidative stress, improve cognitive function and mood, and promote overall quality of life. Participants will self-administer the supplement orally twice daily during the intervention period.
Locations (1)
University of Florida
Gainesville, Florida, United States